A key panel charged with evaluating the first coronavirus vaccine candidate in the US raced against the clock on Thursday in the quest to save American lives — a stark contrast with the dithering, excuses and appalling lack of action on Capitol Hill, where lawmakers are struggling to strike a deal to send emergency pandemic relief to millions of Americans and may fail, once again, to avert a government shutdown at midnight.